Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ACE-041

Known as: ALK1-Fc Fusion Protein ACE-041, Activin Receptor-like Kinase 1 Inhibitor ACE-041 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Development of anti-angiogenic therapy including the vascular endothelial growth factor (VEGF) antibodies and VEGF-tyrosine… Expand
  • table 1
  • figure 1
  • table 2
Highly Cited
2013
Highly Cited
2013
Purpose: The angiogenesis inhibitor dalantercept (formerly ACE-041) is a soluble form of activin receptor–like kinase-1 (ALK1… Expand
  • table 1
  • table 2
  • table 3
2012
2012
Treatment of metastatic RCC with agents that block signaling through VEGFR2 induces disease stabilization or regression in a… Expand
2012
2012
30 Background: Activin receptor-like kinase 1 (ALK1) is a type 1 receptor in the TGF-β superfamily. The ALK1 pathway plays a role… Expand
2011
2011
3070 Background: Activin receptor-like kinase-1 (ALK1) is a type I receptor in the TGFß superfamily expressed on endothelial… Expand
2011
2011
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Background: Activin receptor-like kinase-1 (ALK1) is a… Expand